Results 21 to 30 of about 46,100 (197)
Nutrition in the Era of Highly Active Antiretroviral Therapy [PDF]
Clinical Infectious Diseases, 2001 Despite tremendous advances in treatment, persons with human immunodeficiency virus (HIV) infection commonly experience a variety of nutritional problems, such as weight loss, fat redistribution, and obesity. We discuss basic dietary and metabolic problems as they pertain to persons with HIV infection and provide practical suggestions for their ...
A H, Shevitz, T A, Knox
openaire +2 more sources
Antiretroviral agents against human immunodeficiency virus
DST, 2022 Introduction: Since its discovery in the 1980s, the human immunodeficiency virus (HIV) has been the target of many studies. Nowadays, estimates show that 36.7 million people are infected with HIV worldwide.
Ingrid Barcelos de Oliveira +4 more
doaj
Daily Dosing of Highly Active Antiretroviral Therapy [PDF]
Clinical Infectious Diseases, 2002 Complex treatment schedules for human immunodeficiency virus (HIV) disease, which can have a high pill burden and can include multiple daily doses, in addition to the adverse effects that the medications can cause, may reduce patient adherence to therapy. Reduced adherence prevents achievement of the desired goal of full suppression of HIV replication,
Keith A, Rosenbach +2 more
openaire +2 more sources
BMC Infectious Diseases, 2023 Background To estimate crude mortality, excess mortality, and standardized mortality rates (SMR) among people living with HIV (PLHIV) initiating highly active antiretroviral therapy (HAART) in Luzhou, China 2006–2020, and assess associated factors ...
Dandan Niu +16 more
doaj +1 more source
Highly active antiretroviral therapy: Does it Sound toxic?
Journal of Pharmacy and Bioallied Sciences, 2011 Objective : The main objective of the current study is to monitor the auditory status in a group of adults with AIDS, receiving Highly Active Antiretroviral Therapy (HAART) (3TC -lamivudine, D4T - stavudine, and efavirenz) in a hospital outpatient clinic
Katijah Khoza-Shangase
doaj +1 more source
Update on highly active antiretroviral therapy: progress and strategies [PDF]
Biomedicine & Pharmacotherapy, 2000 HIV patients who have detectable viral loads (1,000-5,000 copies/mL) and/or evidence of immunologic dysfunction (CD4+ T-lymphocyte count < 500/mm3) should be treated with a potent combination antiretroviral regimen. Currently, this is to consist of two nucleoside reverse transcriptase inhibitors (NRTIs) with at least one protease inhibitor (PI), or a ...
Clumeck, Nathan, De Wit, Stéphane
openaire +2 more sources
SAGE Open Medicine, 2021 Objectives: Hematological abnormalities of the major blood cell lines are frequently reported in patients with HIV-1 infection, in patients without antiretroviral therapy, and during the advanced stages of the disease.
Negesso Duguma +3 more
doaj +1 more source
Brazilian Journal of Infectious Diseases, 2017 Objectives: Three decades after HIV recognition and its association with AIDS development, many advances have emerged – especially related to prevention and treatment.
Leonardo J. Galvão-Lima +7 more
doaj +1 more source
Lamivudine’s hypersensitivity in an HIV infected patient: case report
Medicina, 2017 Relevance: To report a case of hypersensitivity to lamivudine, a medicine that is considered safe and is indicated as part of the initial therapy for HIV infected patients.
Vitor R. G. A. Valviesse +4 more
doaj +1 more source
Revista Ciências em Saúde, 2020 Objectives: To evaluate the frequency of HIV serodiscordants couples and their seronegative partners who were candidates for pre-exposure prophylaxis (PrPE), and the knowledge about behavioural measures to reduce virus transmission. Methods: The research
Maíra Gomes Monteiro +3 more
doaj +1 more source